Cara Therapeutics | CARA - Passivo Circulante





Passivo Circulante Alterar Data
Acadia Pharmaceuticals USD 361.44M 55.91M 2026-06
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Cara Therapeutics USD 11.26M 216K 2026-03
Cassava Sciences USD 40.11M 3.72M 2026-03
Chugai Pharma JPY 392.19B 64.49B 2026-06
Cipla INR 70.14B 7.16B 2026-03
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.04M 533K 2026-03
CSL USD 4.61B 207M 2025-12
Grifols EUR 2.37B 156.97M 2025-12
Halozyme Therapeutics USD 344.44M 18.77M 2026-06
J&J USD 54.9B 2.82B 2026-06
Neurocrine Biosciences USD 874.5M 42.8M 2026-06
Pacira USD 122.01M 13.22M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
RedHill Biopharma USD 19.22M 3.07M 2025-12
Supernus Pharmaceuticals USD 347.38M 26.55M 2026-06
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12